Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Jan. 2, 1998

Akzo Nobel describes new gonadotropins with therapeutic potential

Jan. 2, 1998

OGT-918 clinical development program begins

Dec. 30, 1997

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

Dec. 30, 1997

S-22068: effects on glucose tolerance and plasma insulin in mice

Dec. 30, 1997

Boehringer Mannheim presents new calcium regulators

Dec. 30, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

Otsuka's new antidiabetic agents

Dec. 29, 1997

Neurogen updates its NPY program for obesity

Dec. 24, 1997

Biorex and Abbott sign definitive agreement for bimoclomol

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...